Skip to main content
Clinical Trials/NCT06790277
NCT06790277RecruitingNot Applicable

Effectiveness of Polyurethane Foam (Pink Pad) Compared With Mepilex Dressing for Pressure Ulcer Prevention in Operating Room: A Randomized Control Clinical Trial

King Abdullah Medical City1 site in 1 country100 target enrollmentStarted: October 10, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
100
Locations
1
Primary Endpoint
Pressure ulcer incidence

Study Overview

Brief Summary

King Abdullah medical city has a cardiac center, and a lot of open-heart surgeries are performed there, and both polyurethane foam (pink Pad) and Mepilex dressing are applied to those patients. Therefore, the present study was designed to compare the effects of polyurethane foam (pink Pad) versus Mepilex dressing for prevention of pressure ulcer in operating room.

Detailed Description

There are two types of intervention available in King Abdullah medical city for operating room pressure ulcer prevention. Polyurethane foams (Pink Pad) are a single use system for use in surgical procedures. The system consists of a proprietary formulation for the pink foam pad, non-woven lift sheet, body straps, head rests, and boot liners. It aids hospital facilities in providing a safe and effective method of management of the patient for pressure ulcers and non-movement for patients in the Trendelenburg position.

Mepilex Border Sacrum dressings are self-adherent, multilayer foam dressings designed for use on sacrum aiming to prevent pressure ulcers. The dressings are used in addition to standard care protocols for pressure ulcer prevention.

All included patients received standard PU prevention according to hospital protocols, based on contextualization and adaptation of International guidelines ( European Pressure Ulcer Advisory Panel, 2021 ), which involved: assessment of PU risk through the Braden Scale at hospital admission,

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Subjects ≥
  • •Willing to participate.
  • •Patients undergoing cardiac surgery.
  • •Patient who is at risk for PU development as measured with Braden scale.
  • •Patient who has skin intact and having a life expectancy greater than 72 hours as per clinical judgement.

Exclusion Criteria

  • •Subjects under 17
  • •Not consenting to participate
  • •Patients with suspected hypersensitivity reactions to any of the dressing formulation's ingredients.
  • •Patients who are unable to continue the study because of death or change in the care setting.

Arms & Interventions

Polyurethane foams (Pink Pad)

Active Comparator

a single use system for use in surgical procedures.it will be used only by operating room nurses Patient will be examined by wound management team after the operation then at day 3- and 7-days post operation.

Intervention: Polyurethane foams (Pink Pad) (Device)

Mepilex Border Sacrum dressings

Active Comparator

a single use system for use in surgical procedures.it will be used only by operating room nurses Patient will be examined by wound management team after the operation then at day 3- and 7-days post operation.

Intervention: Mepilex Border Sacrum dressings (Device)

Outcomes

Primary Outcomes

Pressure ulcer incidence

Time Frame: 7 days

Pressure ulcer incidence will be assessed by using Bates-Jensen Wound Assessment Tool (BWAT) after operation then day 3 and day 7 for both treatments.

Secondary Outcomes

  • occurrence of pressure ulcer(7 days)

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Ebtisam Abdellatif Ebrahim Elhihi

Nursing Research and Evidence Based Practice Department

King Abdullah Medical City

Study Sites (1)

Loading locations...

Similar Trials